论文部分内容阅读
新生儿弓形虫（T）、衣原体（CT）、解脲支原体（UU）母婴传播问题．至今仍是一项重要优生措施。本文应用阿奇霉素（azithromycin）600mg．给孕妇T－DNA、CT－DNA及UU－DNA．PCR检测阳性孕母．每日1次，口服连服3天，获得了满意效果，320例孕妇经检测，阳性率分别为T－DNA、21．67％±2．31％．CT－DNA为19．33％、2．83％，UU－DNA为17．33％±2．13％。孕妇T－DNA阳性者母婴传播率为48．49％，阴性者235例，传播率为1．28％．P＜0．01。孕妇CT－DNA阳性者，母婴传播率为65．52％．阴性者242例，母婴传播率为0．82％，P＜0．01。孕妇UU－DNA阳性者26例．母婴传播率为57．69％．阴性248例，母婴传播率为1．61％，P＜0．01。孕母T－DNA阳性32例，CT－DNA阳性率29例及UU－DNA阳性26例，母婴传播率便为9．38％、3．45％及11．53％，孕妇阳性与阴性传播率间P＜0．01，新生儿DNA阳性者经治疗后．T－DNA、CT－DNA、及UU－DNA阴转率为100％，95％及94．5％。建议于孕期发现T-DNA、CT-DNA及UU-DNA阳性者应以阿奇霉素防治．以减少胎儿宫内发育不良及畸形儿。
Neonatal Toxoplasma gondii (T), Chlamydia (CT), UU maternal and infant transmission problems. It is still an important preferential measure. This article uses azithromycin (azithromycin) 600mg. To pregnant women T-DNA, CT-DNA and UU-DNA. PCR detection of positive pregnant mother. Once a day, oral and even served for 3 days, obtained satisfactory results, 320 pregnant women after testing, the positive rates were T-DNA, 21.67% ± 2.31%. CT-DNA was 19.33%, 2.83%, UU-DNA was 17.33% ± 2.13%. T-DNA positive pregnant women, maternal and child transmission rate was 48.49%, 235 were negative, the transmission rate was 1.28%. P <0.01. Pregnant women with positive CT-DNA, mother-to-child transmission rate was 65.52%. 242 cases were negative, the mother-infant transmission rate was 0.82%, P <0.01. Pregnant women with UU-DNA were 26 cases. Mother-to-child transmission rate was 57.69%. Negative 248 cases, mother and child transmission rate was 1.61%, P <0.01. T-DNA positive in pregnant women in 32 cases, CT-DNA positive rate in 29 cases and UU-DNA positive in 26 cases, the mother-to-child transmission rate was 9.38%, 3.45% and 11.53%, pregnant women, positive and negative transmission Inter-P <0.01, neonatal DNA positive after treatment. The negative conversion rates of T-DNA, CT-DNA and UU-DNA were 100%, 95% and 94.5%. It is recommended that during pregnancy found T-DNA, CT-DNA and UU-DNA positive should azithromycin control. To reduce intrauterine dysplasia and deformed children.